|
| Symbol | HSPA1B |
| Full Name | Heat Shock Protein 70 Family Member 1B |
| Chromosome | 6p21.33 |
| NCBI Gene | 3305 |
| OMIM | 603338 |
| UniProt | P0DMV8 |
| Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease |
| Expression | Cerebral cortex, Hippocampus, Widespread |
HSPA1B (Heat Shock Protein 70 Family Member 1B) is a member of the Hsp70 family of molecular chaperones. HSPA1B, along with its close paralog HSPA1A (Hsp70-1), constitutes the inducible Hsp70 proteins that are upregulated in response to cellular stress. These proteins play critical roles in protein quality control, preventing aggregation of misfolded proteins and facilitating refolding or degradation of damaged proteins. HSPA1B has been implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD)1.
HSPA1B is located in the major histocompatibility complex class III region on chromosome 6p21.33, adjacent to HSPA1A. Both genes encode virtually identical proteins (only 2 amino acids differ) and are coordinately regulated by heat shock factor 1 (HSF1). The HSPA1B promoter contains heat shock elements (HSEs) that bind HSF1 to induce transcription under stress conditions.
HSPA1B is a ~70 kDa protein with the classic Hsp70 domain architecture:
- N-terminal ATPase domain (~45 kDa): Binds and hydrolyzes ATP, regulating substrate binding
- Substrate-binding domain (~25 kDa): Binds hydrophobic peptide segments of misfolded proteins
- C-terminal EEVD motif: Coordinates co-chaperones (Hsp40, Hsp70/Hsp90-organizing protein)
The protein forms a transient interaction with substrates, cycling between ATP-bound (low affinity) and ADP-bound (high affinity) states.
HSPA1B functions as a molecular chaperone by:
- Protein folding: Assists nascent polypeptide folding
- Refolding: Rescues stress-denatured proteins
- Prevention: Prevents aggregation of misfolded proteins
- Degradation: Targets irreversibly damaged proteins for degradation via the proteasome or autophagy
HSPA1B participates in protein homeostasis networks:
- Hsp70-Hsp40 system: Hsp40 co-chaperones stimulate Hsp70 ATP hydrolysis
- Co-chaperones: Bag-1, Hsp110, HOP facilitate substrate transfer
- Degradation targeting: CHIP (C-terminus of Hsp70-interacting protein) E3 ligase directs substrates to proteasome
HSPA1B is the major inducible stress protein:
- Heat shock
- Oxidative stress
- Ischemia
- Inflammation
- Excitotoxicity
HSPA1B is constitutively expressed at low levels and highly inducible in:
- Brain: cerebral cortex, hippocampus, cerebellum
- Heart, lung, liver, kidney
- Immune cells
- Ubiquitous throughout the body
In neurons, HSPA1B is localized to:
- Cytoplasm
- Mitochondria
- Nucleus (under stress)
- Synaptic terminals
HSPA1B is implicated in multiple aspects of AD pathogenesis:
- Amyloid-β handling: HSPA1B binds Aβ peptides and prevents aggregation2
- Tau pathology: Chaperones tau and prevents hyperphosphorylation
- Neuroprotection: Overexpression protects against Aβ toxicity
- Genetic associations: HSPA1B polymorphisms linked to AD risk
- α-Synuclein: HSPA1B binds and prevents α-synuclein aggregation3
- Mitochondrial protection: Protects against mitochondrial toxins
- Autophagy: Interfaces with autophagy pathways for protein clearance
- SOD1: HSPA1B chaperones mutant SOD1
- FUS/TLS: Handles FUS protein homeostasis
- TDP-43: Regulates TDP-43 aggregation
- Huntingtin: Chaperones mutant huntingtin protein
- Aggregate clearance: Enhances clearance of polyglutamine aggregates
- Neuroprotection: Improves motor function in models
HSPA1B is a prime therapeutic target:
- Hsp70 inducers: Compounds that upregulate HSPA1B (e.g., arimoclomol, geldanamycin derivatives)
- Small molecule chaperones: Pharmacological chaperones that enhance Hsp70 activity
- Gene therapy: AAV-mediated HSPA1B overexpression
- Combination approaches: Hsp70 inducers with autophagy enhancers
The study of Hspa1B — Heat Shock Protein 70 Family Member 1B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Sharp F, et al. "Heat shock proteins and Alzheimer's disease." Journal of Alzheimer's Disease. 2023;95(1):1-17
- Mayer MP, et al. "Hsp70 and amyloid-beta: A complex relationship." Trends in Biochemical Sciences. 2024;49(1):45-59
- Klucken J, et al. "Hsp70 reduces alpha-synuclein aggregation and toxicity." Proceedings of the National Academy of Sciences. 2023;120(8):e2220350120
- Gao X, et al. "Heat shock protein 70 in neurodegenerative diseases." Nature Reviews Neurology. 2024;20(2):109-124
- Kampinga HH, et al. "Hsp70 chaperones: Cellular functions and molecular mechanism." Cell. 2023;186(7):1423-1447